Results 11 to 20 of about 166,209 (279)

Atopic dermatitis [PDF]

open access: yesNature Reviews Disease Primers, 2018
Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life of affected individuals as well as their families. Although the pathogenesis of the disorder is not completely understood, it appears to result from the complex interplay between defects in skin barrier function, environmental and infectious ...
Kenji Kabashima   +2 more
exaly   +10 more sources

Assessment of the severity of atopic dermatitis [PDF]

open access: yesPrzegląd Dermatologiczny, 2016
Atopic dermatitis is a frequent, chronic and recurrent inflammatory skin disease with complex etiology. Typical symptoms of this disease are persistent itching and dry skin.
Agnieszka Bożek, Adam Reich
doaj   +2 more sources

Atopic Dermatitis

open access: yesThe Lancet
Atopic dermatitis is the most common chronic inflammatory skin disease globally. Key features include an eczematous eruption accompanied by intense itch, which can have an enormous negative effect on patients' quality of life, especially in those with moderate-to-severe disease. Atopic dermatitis is part of a spectrum of atopic conditions that can also
Kolb L, Villarreal LA, Sathe NC.
europepmc   +8 more sources

Atopic Dermatitis [PDF]

open access: yesCutis, 2021
A) Pink scaling plaques and erythematous erosions in the antecubital fossae of a 6-year-old White boy. B) Violaceous, hyperpigmented, nummular plaques on the back and extensor surface of the right arm of a 16-month-old Black girl. C) Atopic dermatitis and follicular prominence/accentuation on the neck of a young Black girl.
Candrice R, Heath, Richard P, Usatine
openaire   +6 more sources

The Effect of Vitamin D Supplementation on Atopic Dermatitis [PDF]

open access: yes, 2013
Atopic Dermatitis(AD)is recognized as one of the major worldwide health concerns. Despite being first described in the nineteenth century by Besnier, management options continue to be limited and are primarily palliative.
Albenali, Lujain
core   +6 more sources

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry

open access: yesActa Dermato-Venereologica, 2023
Clinical trials showed that upadacitinib, a selective Janus kinase-1 inhibitor, is effective for treatment of moderate-to-severe atopic dermatitis. However, daily practice studies are limited.
Celeste M. Boesjes   +8 more
doaj   +1 more source

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry

open access: yesActa Dermato-Venereologica, 2021
Dupilumab treatment improves signs, symptoms, and quality of life in patients with moderate-to-severe atopic dermatitis. This study evaluated the impact of dupilumab treatment on absenteeism, presenteeism, and related costs in a large multi-centre cohort
Lieneke F.M. Ariëns   +9 more
doaj   +1 more source

Oral food challenges in children [PDF]

open access: yesKorean Journal of Pediatrics, 2011
Many patients assume that allergic reactions against foods are responsible for triggering or worsening their allergic symptoms. Therefore, it is important to identify patients who would benefit from an elimination diet, while avoiding unnecessary dietary
Hye Yung Yum   +9 more
doaj   +1 more source

Genetic analysis of candidate genes linked to atopic eczema in the Bangladeshi population of East London [PDF]

open access: yes, 2010
PhDBackground: Atopic Eczema (AE) is a common skin disease that results from a complex interplay between genetic and environmental factors. It may be associated with other atopic phenotypes including; asthma, hayfever and food allergy.
Al Kuwaiti, Rauda
core   +4 more sources

High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease

open access: yesClinical and Translational Allergy, 2023
Background The patho‐mechanism of ocular surface disease (OSD) in dupilumab‐treated atopic dermatitis (AD) patients remains unclear. The aim of this study is to measure dupilumab levels in tear fluid and serum, and relate these findings to the severity ...
Roselie Achten   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy